Results 191 to 200 of about 143,820 (254)

Clonal hematopoiesis of indeterminate potential (CHIP), vascular somatic mutation, and cardiovascular disease: A narrative review. [PDF]

Vasc Med
Powell N, Cubbon RM, Bailey MA, Griffin KJ, Roberts L, Cheng C.   +5 more
europepmc   +1 more source

Association of infection frequency and incident clonal hematopoiesis of indeterminant potential. [PDF]

Exp Hematol
Lapite A, Burk VA, DeCuir J, Ishigami J, Saadatagah S, Natarajan P, Ballantyne CM, Platz EA, King KY.   +8 more
europepmc   +1 more source

Flow cytometric assessment of T‐cell receptor β‐chain constant region 1/2 skewing as a surrogate marker for clonality in human T‐cell leukaemia virus type‐1–infected cells

British Journal of Haematology, EarlyView.
Summary Estimating T‐cell clonality within human T‐cell leukaemia virus type 1 (HTLV‐1)–infected cell populations may aid risk assessment and diagnosis of adult T‐cell leukaemia/lymphoma (ATL). However, direct assessment of HTLV‐1 integration‐site clonality requires genetic analyses that are costly and labour‐intensive.
Koji Jimbo, Aileen G. Rowan, Momoko Usui, Kako Suzuki, Makoto Yamagishi, Junya Makiyama, Lucy B. M. Cook, Yoshihisa Yamano, Kaoru Uchimaru, Yasuhito Nannya, Shigeo Fuji   +10 more
wiley   +1 more source

Association of Clonal Hematopoiesis With Incident, Late-Onset, Seropositive Rheumatoid Arthritis. [PDF]

Arthritis Rheumatol
Zhao K, Pershad Y, Heimlich JB, Ormseth M, Stein CM, Sharber B, Vlasschaert C, Bick AG, Corty RW.   +8 more
europepmc   +1 more source

Clinical Impact and Dynamics of Clonal Hematopoiesis with ¹⁷⁷Lu-PSMA-617 Therapy in Advanced Prostate Cancer. [PDF]

J Nucl Med
Ravi P, Zhong C, Perez KJ, Xie W, Volpe V, Lee GM, Boardman J, Pittard EG, Stoltenberg H, Jacene H, Weeks LD, Sperling AS.   +11 more
europepmc   +1 more source

The role of the adenosinergic pathway in resistance to hypomethylating agents in patients with high‐risk myelodysplastic syndromes

British Journal of Haematology, EarlyView.
George Vrachiolias, Eleftheria Lamprianidou, Athanasios Tasis, Theodoros Spyropoulos, Despoina Dimitriou, Chryssa Kymparidou, Christina Misidou, Konstantinos Liapis, Emmanouil Spanoudakis, Maria Koffa, Menelaos Papoutselis, Iliana Stamatiou, Elsa Bernard, Elli Papaemmanuil, Ioannis Mitroulis, Ioannis Kotsianidis   +15 more
wiley   +1 more source

Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory FLT3‐ITD–Positive AML

Cancer Science, EarlyView.
ABSTRACT Quizartinib is a FMS‐like tyrosine kinase 3 (FLT3) inhibitor indicated for FLT3 internal tandem duplication (FLT3‐ITD)–positive acute myeloid leukemia (AML). We aimed to evaluate quizartinib resistance mechanisms, in addition to efficacy and safety outcomes, in patients with relapsed or refractory FLT3‐ITD–positive AML.
Yuichiro Semba, Toshihiro Miyamoto, Senji Kasahara, Yoshikane Kikushige, Takahiro Maeda, Goichi Yoshimoto, Shuichi Ota, Akio Saito, Yuho Najima, Hiroki Hosoi, Daigo Niiya, Koji Kato, Koji Nagafuji, Takashi Akasaka, Tomohiko Kamimura, Atsushi Takita, Maiko Narahara, Tadashi Toki, Koichi Iwanaga, Koji Yonemoto, Mine Harada, Koichi Akashi   +21 more
wiley   +1 more source

Impaired Glycolysis Leads to Defective Efferocytosis and Impaired Plaque Resolution in <i>Tet2</i> Clonal Hematopoiesis. [PDF]

Circulation
Yalcinkaya M, Hsu CC, Li L, Wang R, Ngai D, Sánchez Vela P, Fernandez-Maestre I, Olszewska M, Liu W, Chen M, Schiavone S, Xiao T, Papapetrou EP, Wang N, Levine R, Yu Z, Tabas I, Tall AR.   +17 more
europepmc   +1 more source

Real‐world evidence on the safety and effectiveness of thrombopoietin receptor agonists in aplastic anaemia: A descriptive study using Japanese hospital administrative data

British Journal of Haematology, EarlyView.
Kayoko Mizuno, Yutaka Shimazu, Toshiki Fukasawa, Satoru Ito, Yukihiro Nishio, Mami Shimizu, Koji Kawakami   +6 more
wiley   +1 more source